Methylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III study
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Conference item |
Published: |
2018
|
_version_ | 1797100394905600000 |
---|---|
author | Repici, A Wallace, M East, J Sharma, P Bisschops, R Ramirez, F Bruining, D Young, M Gatof, D Canto, M Marcon, N Cannizzaro, R Kiesslich, R Rutter, M Dekker, E Siersema, P Spaander, M Kupcinskas, L Radaelli, F Bhandari, P Vieth, M Hassan, C |
author2 | Elsevier |
author_facet | Elsevier Repici, A Wallace, M East, J Sharma, P Bisschops, R Ramirez, F Bruining, D Young, M Gatof, D Canto, M Marcon, N Cannizzaro, R Kiesslich, R Rutter, M Dekker, E Siersema, P Spaander, M Kupcinskas, L Radaelli, F Bhandari, P Vieth, M Hassan, C |
author_sort | Repici, A |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T05:36:51Z |
format | Conference item |
id | oxford-uuid:e431f3f8-f405-476d-8bc9-d196ba420c15 |
institution | University of Oxford |
last_indexed | 2024-03-07T05:36:51Z |
publishDate | 2018 |
record_format | dspace |
spelling | oxford-uuid:e431f3f8-f405-476d-8bc9-d196ba420c152022-03-27T10:14:51ZMethylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III studyConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:e431f3f8-f405-476d-8bc9-d196ba420c15Symplectic Elements at Oxford2018Repici, AWallace, MEast, JSharma, PBisschops, RRamirez, FBruining, DYoung, MGatof, DCanto, MMarcon, NCannizzaro, RKiesslich, RRutter, MDekker, ESiersema, PSpaander, MKupcinskas, LRadaelli, FBhandari, PVieth, MHassan, CElsevier |
spellingShingle | Repici, A Wallace, M East, J Sharma, P Bisschops, R Ramirez, F Bruining, D Young, M Gatof, D Canto, M Marcon, N Cannizzaro, R Kiesslich, R Rutter, M Dekker, E Siersema, P Spaander, M Kupcinskas, L Radaelli, F Bhandari, P Vieth, M Hassan, C Methylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III study |
title | Methylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III study |
title_full | Methylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III study |
title_fullStr | Methylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III study |
title_full_unstemmed | Methylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III study |
title_short | Methylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III study |
title_sort | methylene blue mmx r increases adenoma detection rate in screening and surveillance colonoscopy a multi centre multinational placebo controlled randomised double blind at randomisation parallel group phase iii study |
work_keys_str_mv | AT repicia methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT wallacem methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT eastj methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT sharmap methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT bisschopsr methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT ramirezf methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT bruiningd methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT youngm methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT gatofd methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT cantom methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT marconn methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT cannizzaror methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT kiesslichr methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT rutterm methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT dekkere methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT siersemap methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT spaanderm methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT kupcinskasl methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT radaellif methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT bhandarip methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT viethm methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy AT hassanc methylenebluemmxrincreasesadenomadetectionrateinscreeningandsurveillancecolonoscopyamulticentremultinationalplacebocontrolledrandomiseddoubleblindatrandomisationparallelgroupphaseiiistudy |